Baseline albumin (b-alb) as a potential predictive biomarker for the efficacy of bevacizumab (B) therapy (tx) in patients (pts) with advanced pancreas cancer (APCA): A comparative analysis.
Ludmila Katherine Martin
No relevant relationships to disclose
Susan Michelle Geyer
No relevant relationships to disclose
Anissa Bingman
No relevant relationships to disclose
Mark M. Zalupski
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech